Gains in cancer survival at risk due to surge in multi-drug resistant superbugs
May 4, 2017
| By Mary Engel / Fred Hutch News Service
Antibiotics and other antimicrobials are unique among medications, a “shared resource” that we need to preserve, much as we steward our environment and natural resources, says Fred Hutch clinician-infectious disease researcher Dr. Catherine Liu. Overuse or misuse can lead to drug-resistant bugs that can then spread to new hosts and in some cases even spread their resistance genes to different microorganisms, posing a risk to society at large.
The $100,000 one-year grant will fund the development of a new class of antimicrobial drugs to treat TB and limit the evolution of resistance to antibiotics
May 11, 2009
| By Dean Forbes
A project by the Fred Hutchinson Cancer Research Center's Dr. Gerald Smith to find new antibiotics to treat TB and to simultaneously limit the evolution of resistance to antibiotics was selected for funding by the Bill & Melinda Gates Foundation Grand Challenges in Global Health. The $100,000, one-year grant was one of 81 awarded by the organization worldwide in early May.